Published in EMBO J on December 15, 2003
Epigenetic mechanisms in Alzheimer's disease. Neurobiol Aging (2011) 3.83
The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res (2004) 3.30
Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci (2009) 2.95
Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J Cell Biol (2005) 2.34
HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ (2006) 1.82
Flavivirus activates phosphatidylinositol 3-kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection. J Virol (2005) 1.53
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev (2013) 1.52
Nuclear Condensation during Mouse Erythropoiesis Requires Caspase-3-Mediated Nuclear Opening. Dev Cell (2016) 1.49
Targets of caspase-6 activity in human neurons and Alzheimer disease. Mol Cell Proteomics (2008) 1.48
Cleavage and cytoplasmic relocalization of histone deacetylase 3 are important for apoptosis progression. Mol Cell Biol (2006) 1.46
Neuroprotection by histone deacetylase-related protein. Mol Cell Biol (2006) 1.37
Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells. Mol Cell Biol (2005) 1.27
Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury. FASEB J (2009) 1.23
Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B/H4 acetylation-dependent transcriptional events in the rat hippocampus. Neuropsychopharmacology (2010) 1.21
Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis. BMC Neurosci (2010) 1.20
Calpain activity and muscle wasting in sepsis. Am J Physiol Endocrinol Metab (2008) 1.14
CREB binding protein is required for both short-term and long-term memory formation. J Neurosci (2010) 1.14
TNF-alpha preconditioning protects neurons via neuron-specific up-regulation of CREB-binding protein. J Immunol (2009) 1.12
CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy. Hum Mol Genet (2011) 1.12
Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2. EMBO J (2006) 1.10
Exercise and sodium butyrate transform a subthreshold learning event into long-term memory via a brain-derived neurotrophic factor-dependent mechanism. Neuropsychopharmacology (2013) 1.10
Fraternal twins: Swiprosin-1/EFhd2 and Swiprosin-2/EFhd1, two homologous EF-hand containing calcium binding adaptor proteins with distinct functions. Cell Commun Signal (2011) 1.09
Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease. Neuroscientist (2011) 1.08
Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration. Mol Pharmacol (2010) 1.05
Scriptaid, a novel histone deacetylase inhibitor, protects against traumatic brain injury via modulation of PTEN and AKT pathway : scriptaid protects against TBI via AKT. Neurotherapeutics (2013) 1.04
Alcohol exposure decreases CREB binding protein expression and histone acetylation in the developing cerebellum. PLoS One (2011) 1.00
Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling. Mol Cell Neurosci (2007) 0.98
Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells. Mol Vis (2011) 0.98
Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. J Nutr Biochem (2010) 0.97
Tip60 HAT activity mediates APP induced lethality and apoptotic cell death in the CNS of a Drosophila Alzheimer's disease model. PLoS One (2012) 0.96
Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition. Brain Res (2010) 0.96
Streptococcus pneumoniae-induced caspase 6-dependent apoptosis in lung epithelium. Infect Immun (2004) 0.94
Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries. Mol Med (2011) 0.93
Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders. Curr Pharm Des (2013) 0.93
Molecular mechanisms of synaptic remodeling in alcoholism. Neurosci Lett (2015) 0.89
Histone acetylation and CREB binding protein are required for neuronal resistance against ischemic injury. PLoS One (2014) 0.89
Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration. Neurotoxicology (2011) 0.89
Increasing Tip60 HAT levels rescues axonal transport defects and associated behavioral phenotypes in a Drosophila Alzheimer's disease model. J Neurosci (2013) 0.89
Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities. Front Cell Neurosci (2013) 0.86
Epigenetic mechanisms of Rubinstein-Taybi syndrome. Neuromolecular Med (2014) 0.86
Histone acetylation inhibitors promote axon growth in adult dorsal root ganglia neurons. J Neurosci Res (2015) 0.86
Valosin-containing protein (VCP) in novel feedback machinery between abnormal protein accumulation and transcriptional suppression. J Biol Chem (2010) 0.86
Lithium down-regulates histone deacetylase 1 (HDAC1) and induces degradation of mutant huntingtin. J Biol Chem (2013) 0.85
Metabolism, longevity and epigenetics. Cell Mol Life Sci (2013) 0.85
Increased EID1 nuclear translocation impairs synaptic plasticity and memory function associated with pathogenesis of Alzheimer's disease. Neurobiol Dis (2011) 0.85
CREB-binding protein levels in the rat hippocampus fail to predict chronological or cognitive aging. Neurobiol Aging (2012) 0.83
Acetyltransferases (HATs) as targets for neurological therapeutics. Neurotherapeutics (2013) 0.83
Involvement of {beta}-catenin and unusual behavior of CBP and p300 in glucocorticosteroid signaling in Schwann cells. Proc Natl Acad Sci U S A (2005) 0.81
Multitasking C2H2 zinc fingers link Zac DNA binding to coordinated regulation of p300-histone acetyltransferase activity. Mol Cell Biol (2006) 0.81
The combination of lithium and l-Dopa/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson׳s disease therapy. Brain Res (2015) 0.81
Epigenetics of neural repair following spinal cord injury. Neurotherapeutics (2013) 0.81
Characterization of a new SUMO-1 nuclear body (SNB) enriched in pCREB, CBP, c-Jun in neuron-like UR61 cells. Chromosoma (2007) 0.81
Caspase-mediated proteolysis of the sorting nexin 2 disrupts retromer assembly and potentiates Met/hepatocyte growth factor receptor signaling. Cell Death Discov (2017) 0.81
General Anesthesia Causes Epigenetic Histone Modulation of c-Fos and Brain-derived Neurotrophic Factor, Target Genes Important for Neuronal Development in the Immature Rat Hippocampus. Anesthesiology (2016) 0.80
Expression and activation of caspase-6 in human fetal and adult tissues. PLoS One (2013) 0.80
Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors. Br J Pharmacol (2015) 0.80
Histone Acetylation Modifiers in the Pathogenesis of Alzheimer's Disease. Front Cell Neurosci (2015) 0.80
Matters of life and death: the role of chromatin remodeling proteins in retinal neuron survival. J Ocul Biol Dis Infor (2012) 0.79
Epigenetics components of aging in the central nervous system. Neurotherapeutics (2013) 0.79
Histone acetyltransferase p300 mediates histone acetylation of PS1 and BACE1 in a cellular model of Alzheimer's disease. PLoS One (2014) 0.78
Emerging roles of epigenetic mechanisms in Parkinson's disease. Funct Integr Genomics (2011) 0.78
Targeting histone deacetylases: a novel approach in Parkinson's disease. Parkinsons Dis (2015) 0.78
Tip off the HAT- Epigenetic control of learning and memory by Drosophila Tip60. Fly (Austin) (2015) 0.77
Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate. Neurosci Lett (2015) 0.77
Immunohistochemical localization of cyclic AMP-responsive element binding protein (CREB)-binding protein in the pig retina during postnatal development. Anat Cell Biol (2011) 0.76
Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways. Cell Death Dis (2014) 0.76
Loss of GCN5 leads to increased neuronal apoptosis by upregulating E2F1- and Egr-1-dependent BH3-only protein Bim. Cell Death Dis (2017) 0.75
4'-O-β-D-glucosyl-5-O-methylvisamminol, an active ingredient of Saposhnikovia divaricata, attenuates high-mobility group box 1 and subarachnoid hemorrhage-induced vasospasm in a rat model. Behav Brain Funct (2015) 0.75
Purpurogallin, a natural phenol, attenuates high-mobility group box 1 in subarachnoid hemorrhage induced vasospasm in a rat model. Int J Vasc Med (2014) 0.75
Caspase-6 mediates resistance against Burkholderia pseudomallei infection and influences the expression of detrimental cytokines. PLoS One (2017) 0.75
Expression of histone acetylases p300 and PCAF in pediatric astrocytomas. Childs Nerv Syst (2013) 0.75
Treadmill exercise alters histone acetyltransferases and histone deacetylases activities in frontal cortices from wistar rats. Cell Mol Neurobiol (2014) 0.75
Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature (1993) 11.54
Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J (2003) 11.27
The CBP co-activator is a histone acetyltransferase. Nature (1997) 10.91
Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature (1994) 9.37
Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev (2000) 9.36
Function and regulation of CREB family transcription factors in the nervous system. Neuron (2002) 7.99
Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays (1998) 7.79
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature (1995) 7.11
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature (2001) 6.76
Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell (1998) 6.73
p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci (2001) 5.74
Signaling to chromatin through histone modifications. Cell (2000) 5.36
CREB-binding protein and p300 in transcriptional regulation. J Biol Chem (2001) 4.67
Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep (2002) 4.13
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A (2000) 4.01
Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci U S A (1993) 3.18
Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (1995) 2.79
Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV. Neuron (2002) 2.45
CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV. Science (1998) 2.41
Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. Neuron (2002) 2.17
Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease. J Biol Chem (1999) 2.00
Histone acetylation and chromatin remodeling. Exp Cell Res (2001) 1.85
Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation. EMBO J (2002) 1.82
FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Exp Cell Res (1998) 1.78
Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2000) 1.72
Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J Neurosci (1996) 1.56
Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc Natl Acad Sci U S A (1998) 1.55
Regulation of CBP-mediated transcription by neuronal calcium signaling. Neuron (1999) 1.48
SATB1 cleavage by caspase 6 disrupts PDZ domain-mediated dimerization, causing detachment from chromatin early in T-cell apoptosis. Mol Cell Biol (2001) 1.48
Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis. J Neurochem (2003) 1.37
Biochemical determinants of apoptosis and necrosis. Toxicol Lett (1998) 1.33
Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. Hum Mol Genet (2003) 1.22
Proteolytic cleavage of the mdm2 oncoprotein during apoptosis. J Biol Chem (1997) 1.20
Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis. Cell Death Differ (2000) 1.19
Apoptosis and neurologic disease. Am J Med (2000) 1.17
Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome. Hum Mol Genet (2003) 1.16
Familial amyotrophic lateral sclerosis. Muscle Nerve (2002) 1.12
The role of apoptosis in normal and abnormal embryonic development. J Assist Reprod Genet (1999) 1.05
Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis. Proc Natl Acad Sci U S A (1999) 1.05
Alteration of the Bcl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: evidence for the implication of the p53 signaling pathway. Neurobiol Dis (2000) 1.01
Caspases on the brain. J Neurosci Res (2002) 0.96
Anti-apoptotic wild-type Alzheimer amyloid precursor protein signaling involves the p38 mitogen-activated protein kinase/MEF2 pathway. Brain Res Mol Brain Res (2002) 0.92
Caspase-dependent cleavage of the retinoblastoma protein is an early step in neuronal apoptosis. Oncogene (2000) 0.92
Amyloid precursor protein family-induced neuronal death is mediated by impairment of the neuroprotective calcium/calmodulin protein kinase IV-dependent signaling pathway. J Biol Chem (2002) 0.91
Depolarization regulates cyclin D1 degradation and neuronal apoptosis: a hypothesis about the role of the ubiquitin/proteasome signalling pathway. Eur J Neurosci (1999) 0.90
Molecular regulation of neuronal apoptosis. Curr Top Dev Biol (1998) 0.88
Histone modifications and apoptosis: cause or consequence? Biochem Cell Biol (2001) 0.82
c-Jun regulation in rat neonatal motoneurons postaxotomy. J Neurosci Res (2001) 0.80
Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes. Ann Neurol (2007) 2.37
Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A (2004) 2.26
Guidelines for preclinical animal research in ALS/MND: A consensus meeting. Amyotroph Lateral Scler (2010) 2.14
Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol (2010) 2.00
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc Natl Acad Sci U S A (2007) 1.78
Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types. J Biol Chem (2005) 1.61
Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J Neurosci (2007) 1.52
Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Curr Opin Pharmacol (2009) 1.47
Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS One (2009) 1.45
Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis. J Neurochem (2003) 1.37
Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Physiol Genomics (2007) 1.31
HP1alpha guides neuronal fate by timing E2F-targeted genes silencing during terminal differentiation. EMBO J (2007) 1.31
Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders. Biochem Pharmacol (2004) 1.22
Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B/H4 acetylation-dependent transcriptional events in the rat hippocampus. Neuropsychopharmacology (2010) 1.21
Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2010) 1.20
The protein kinase A inhibitor H89 acts on cell morphology by inhibiting Rho kinase. J Pharmacol Exp Ther (2002) 1.20
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis. Neurobiol Dis (2002) 1.17
Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases. Biochim Biophys Acta (2010) 1.13
Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann Neurol (2012) 1.12
Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis. FASEB J (2003) 1.11
Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann Neurol (2005) 1.11
Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res (2007) 1.09
The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep (2006) 1.09
A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons. Hum Mol Genet (2010) 1.09
Mitochondria in amyotrophic lateral sclerosis: a trigger and a target. Neurodegener Dis (2004) 1.07
A ruthenium-containing organometallic compound reduces tumor growth through induction of the endoplasmic reticulum stress gene CHOP. Cancer Res (2009) 1.06
Cyclin-dependent kinases phosphorylate p73 at threonine 86 in a cell cycle-dependent manner and negatively regulate p73. J Biol Chem (2003) 1.05
Mice with a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack motor neuron disease. Exp Neurol (2008) 1.05
Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation. FASEB J (2002) 1.04
Constitutive repression of E2F1 transcriptional activity through HDAC proteins is essential for neuronal survival. Ann N Y Acad Sci (2002) 1.00
Amyotrophic lateral sclerosis: all roads lead to Rome. J Neurochem (2007) 0.99
Diffusion-weighted MRI of denervated muscle: a clinical and experimental study. Skeletal Radiol (2008) 0.96
Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age. Neurobiol Dis (2013) 0.96
A novel activator of CBP/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice. J Neurosci (2013) 0.95
Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man. Exp Neurol (2005) 0.93
BBS-induced ciliary defect enhances adipogenesis, causing paradoxical higher-insulin sensitivity, glucose usage, and decreased inflammatory response. Cell Metab (2012) 0.93
Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis. Free Radic Biol Med (2010) 0.93
Nogo receptor antagonizes p75NTR-dependent motor neuron death. Proc Natl Acad Sci U S A (2008) 0.91
Amyloid precursor protein family-induced neuronal death is mediated by impairment of the neuroprotective calcium/calmodulin protein kinase IV-dependent signaling pathway. J Biol Chem (2002) 0.91
Induction of caspase 8 and reactive oxygen species by ruthenium-derived anticancer compounds with improved water solubility and cytotoxicity. Biochem Pharmacol (2012) 0.91
Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis. Hum Mol Genet (2013) 0.89
P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis. Neurosci Lett (2010) 0.88
Muscle gene expression is a marker of amyotrophic lateral sclerosis severity. Neurodegener Dis (2011) 0.88
Detection of histone acetylation levels in the dorsal hippocampus reveals early tagging on specific residues of H2B and H4 histones in response to learning. PLoS One (2013) 0.87
The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice. Biomed Pharmacother (2005) 0.87
Tissue specificity and regulation of the N-terminal diversity of reticulon 3. Biochem J (2005) 0.86
Rho GTPases and phosphoinositide 3-kinase organize formation of branched dendrites. J Biol Chem (2003) 0.86
Elevated levels of amyloid precursor protein in muscle of patients with amyotrophic lateral sclerosis and a mouse model of the disease. Muscle Nerve (2006) 0.85
Mutations in cytoplasmic dynein lead to a Huntington's disease-like defect in energy metabolism of brown and white adipose tissues. Biochim Biophys Acta (2010) 0.85
The beta-amyloid precursor protein controls a store-operated Ca2+ entry in cortical neurons. Eur J Neurosci (2004) 0.84
Acetyltransferases (HATs) as targets for neurological therapeutics. Neurotherapeutics (2013) 0.83
Platelet serotonin level predicts survival in amyotrophic lateral sclerosis. PLoS One (2010) 0.82
Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity. Brain (2012) 0.82
Fatting the brain: a brief of recent research. Front Cell Neurosci (2013) 0.82
Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis. Mol Cell Neurosci (2002) 0.81
HDAC-3 participates in the repression of e2f-dependent gene transcription in primary differentiated neurons. Ann N Y Acad Sci (2004) 0.81
Mitochondrial dysfunction in amyotrophic lateral sclerosis also affects skeletal muscle. Muscle Nerve (2006) 0.81
The Onecut transcription factor HNF-6 regulates in motor neurons the formation of the neuromuscular junctions. PLoS One (2012) 0.80
Reticulons as markers of neurological diseases: focus on amyotrophic lateral sclerosis. Neurodegener Dis (2005) 0.80
Antibody-bound beta-amyloid precursor protein stimulates the production of tumor necrosis factor-alpha and monocyte chemoattractant protein-1 by cortical neurons. Neurobiol Dis (2005) 0.79
Systemic down-regulation of delta-9 desaturase promotes muscle oxidative metabolism and accelerates muscle function recovery following nerve injury. PLoS One (2013) 0.79
Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons. J Biol Chem (2011) 0.79
Electrophysiological studies in a mouse model of Schwartz-Jampel syndrome demonstrate muscle fiber hyperactivity of peripheral nerve origin. Muscle Nerve (2009) 0.79
A mutation in the dynein heavy chain gene compensates for energy deficit of mutant SOD1 mice and increases potentially neuroprotective IGF-1. Mol Neurodegener (2011) 0.78
Modulation of neurogenesis by targeting epigenetic enzymes using small molecules: an overview. ACS Chem Neurosci (2014) 0.78
Sp3 and sp4 transcription factor levels are increased in brains of patients with Alzheimer's disease. Neurodegener Dis (2007) 0.78
Early activation of antioxidant mechanisms in muscle of mutant Cu/Zn-superoxide dismutase-linked amyotrophic lateral sclerosis mice. Ann N Y Acad Sci (2003) 0.78
Neuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models. Neuroendocrinology (2003) 0.78
Pituitary adenylyl cyclase-activating polypeptide 38 reduces astroglial proliferation by inhibiting the GTPase RhoA. J Biol Chem (2005) 0.77
Comparative analysis of the time-dependent functional and molecular changes in spinal cord degeneration induced by the G93A SOD1 gene mutation and by mechanical compression. BMC Genomics (2008) 0.77
[Amyotrophic lateral sclerosis: role of energy deficiency in neuromuscular junction dismantlement]. Med Sci (Paris) (2008) 0.76
Full-length PGC-1α salvages the phenotype of a mouse model of human neuropathy through mitochondrial proliferation. Hum Mol Genet (2013) 0.75
Lesions and genes: on the edge of improved isomorphic models for Alzheimer's disease? Neurodegener Dis (2008) 0.75
[Cellular prion protein: more than what beyond spongiform encephalopathies]. Med Sci (Paris) (2003) 0.75
Denervation is not a primary cause of prion protein down-regulation occurring in the spinal cord of a transgenic model of amyotrophic lateral sclerosis. Ann N Y Acad Sci (2002) 0.75
[Epigenetic regulations and cerebral plasticity: towards new therapeutic options in neurodegenerative diseases?] Biol Aujourdhui (2017) 0.75